IDH2 and glioma: Expression of GPR133 was significantly higher in the core (bulk) of IDH wild-type gliomas, when compared to IDH mutant (including both 1p19q codeleted and non-codeleted subgroups) and BRAF mutant tumors (Figure 4Ai).